Pilot Study of Augment Rotator Cuff for Surgical Treatment of Full Thickness Rotator Cuff Tears

NCT ID: NCT01256242

Last Updated: 2019-02-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

31 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-11-24

Study Completion Date

2012-11-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study Purpose: To evaluate the safety and performance of Augment Rotator Cuff as a primary surgical treatment for full thickness rotator cuff tears. The hypothesis is that Augment Rotator Cuff will be easy to deliver as an inter-positional graft placed between the rotator cuff tendon and the humeral head providing further enhanced tendon to bone healing without adding any additional safety risk to the patient.

Study Rationale: To evaluate the safety and performance Augment™ Rotator Cuff in surgical intervention of a torn rotator cuff and to obtain preliminary data to support the rationale for a subsequent pivotal clinical trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Full Thickness Rotator Cuff Tear

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Standard Suture Repair + Augment Rotator Cuff

Group Type EXPERIMENTAL

Augment Rotator Cuff

Intervention Type DEVICE

rhPDGF-BB and bovine collagen matrix

Group 2

Standard Suture Repair

Group Type ACTIVE_COMPARATOR

Standard Suture Repair

Intervention Type PROCEDURE

standard suture repair

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Augment Rotator Cuff

rhPDGF-BB and bovine collagen matrix

Intervention Type DEVICE

Standard Suture Repair

standard suture repair

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The subject has a repairable rotator cuff tear with an estimated full thickness size of ≥ 2 cm to \< 5 cm confirmed with diagnostic MRI in AP or ML dimension
* The subject is independent, ambulatory, and can comply with all post-operative evaluations and visits
* The subject is at least twenty one (21) years of age and considered to be skeletally mature.

Exclusion Criteria

* The subject has undergone previous rotator cuff repair surgery to the affected shoulder
* The subject has a partial thickness rotator cuff tear
* The subject requires a concomitant subscapularis repair
* The subject requires a concomitant labral repair
* The subject has an irreparable rotator cuff tear
* The subject has an allergy to yeast-derived products or a known bovine collagen allergy
* The subject has implanted metallic devices (cardiac pacemakers, insulin pumps, and nerve stimulators), medically implanted clips or other electronically, magnetically or mechanically activated implants that would contraindicate undergoing an MRI scan of the shoulder
* The subject has tested positive or has been treated for a malignancy in the past or is suspected of having a malignancy or is currently undergoing radiation or chemotherapy treatment for a malignancy anywhere in the body, whether adjacent to or distant from the proposed Augment Rotator Cuff implantation site
* The subject's condition represents a worker's compensation case
* The subject is currently involved in a health-related litigation procedure
* The subject is pregnant or able to become pregnant but not practicing a medically-accepted form of birth control, and/or intending to become pregnant during this study period
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

BioMimetic Therapeutics

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert Litchfield, MD, FRCSC

Role: PRINCIPAL_INVESTIGATOR

Fowler Kennedy Sport Medicine Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fowler Kennedy Sports Medicine Clinic

London, Ontario, Canada

Site Status

Hand and Upper Limb Clinic - St. Joseph's Health Care London

London, Ontario, Canada

Site Status

Ottawa Hospital

Ottawa, Ontario, Canada

Site Status

St. Michaels Hospital

Toronto, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Related Links

Access external resources that provide additional context or updates about the study.

http://www.aaos.org

American Academy of Orthopaedic Surgeons

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BMTI-2010-03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.